Complain about a product or service

FDA Studies Asthma Drug's Potential Suicide Link

Reports from patients taking Singulair spark probe

By Mark Huffman
ConsumerAffairs.com

March 27, 2008

Asthma • FDA Studies Asthma Drug's Potential Suicide Link • Indoor Allergens Torment Asthma Sufferers • Patients Balk at New Asthma Inhalers • Study: Farm Kids Have Lower Risk of Asthma • Researchers Link Spray Cleaners With Asthma • National Study Links Asthma to Allergies • Study Finds High Rate of Asthma in College Athletes • Can an Apple a Day Keep Asthma Away? • Survey Shows Asthma Not Controlled in Majority of Patients • Asthma Patients Pay the Price for Ozone Protection • Asthma Linked to Obesity in Women • Researchers Say "Killer" Asthma Inhalers Should Be Recalled • Asthmatic Kids Need No-Smoking Rules • Study: Asthma Patients Think It's Temporary • Female Hormones May Affect Allergies, Asthma • Home-Based Clean-Ups Help Childhood Asthma, Study Finds • Asthma and Obesity: Is There A Connection? • Bacteria in Household Dust May Trigger Asthma Symptoms • Air Pollution, Asthma May Be Linked • Americans Lack Vital Asthma Info: EPA • Researchers Find Ties Between Asthma and Emotion • A Good Laugh Can Trigger Asthma Attack

The U.S. Food and Drug Administration is looking into a potential link between an asthma drug manufactured by Merck & Co. and suicidal behavior. The drug in questions, says the FDA, is Singulair.

The agency says its probe was sparked by an undisclosed number of reports of suicidal tendencies and thinking among patients using the drug. Most people taking the drug are using it to treat both allergy and asthma symptoms.

Merck describes the drug as "a prescription medicine approved to help control symptoms of asthma in adults and children 12 months and older and for relief of symptoms of indoor and outdoor allergies (outdoor allergies in adults and children as young as 2 years and indoor allergies in adults and children as young as 6 months)."

It says side effects are generally mild and vary by age, and may include headache, ear infection, sore throat, and upper respiratory infection.

The FDA stressed that it had not made a definite link between the drug and suicidal behavior, and that its investigation into a possible link could take up to nine months. It has also asked Merck to recheck its research data to look for any possible link or troubling trend.

Report Your Experience
If you've had a bad experience -- or a good one -- with a consumer product or service, we'd like to hear about it. All complaints are reviewed by class action attorneys and are considered for publication on our site. Knowledge is power! Help spread the word. File your consumer report now.

Back to the top |